Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Methodol. Jun 26, 2014; 4(2): 73-90
Published online Jun 26, 2014. doi: 10.5662/wjm.v4.i2.73
Figure 1
Figure 1 Progress in the treatment of multiple myeloma[127].
Figure 2
Figure 2 Chemical structure of bortezomib and new proteasome inhibitors carfilzomib, delanzomib (CEP18770), marizomib (NPI-0052) and ixazomib (MLN9708).
Figure 3
Figure 3 Chemical structures of thalidomide and its analogues, lenalidomide (CC-5013) and pomalidomide (CC-4047).